196 related articles for article (PubMed ID: 8060496)
1. Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP.
Liwo A; Gibson KD; Scheraga HA; Brandt-Rauf PW; Monaco R; Pincus MR
J Protein Chem; 1994 Feb; 13(2):237-51. PubMed ID: 8060496
[TBL] [Abstract][Full Text] [Related]
2. Activated conformations of the ras-gene-encoded p21 protein. 1. An energy-refined structure for the normal p21 protein complexed with GDP.
Dykes DC; Brandt-Rauf P; Luster SM; Chung D; Friedman FK; Pincus MR
J Biomol Struct Dyn; 1992 Jun; 9(6):1025-44. PubMed ID: 1637501
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the computed three-dimensional structures of oncogenic forms (bound to GDP) of the ras-gene-encoded p21 protein with the structure of the normal (non-transforming) wild-type protein.
Monaco R; Chen JM; Chung D; Brandt-Rauf P; Pincus MR
J Protein Chem; 1995 Aug; 14(6):457-66. PubMed ID: 8593186
[TBL] [Abstract][Full Text] [Related]
4. Structural effects of the binding of GTP to the wild-type and oncogenic forms of the ras-gene-encoded p21 proteins.
Monaco R; Chen JM; Friedman FK; Brandt-Rauf P; Chung D; Pincus MR
J Protein Chem; 1995 Nov; 14(8):721-9. PubMed ID: 8747433
[TBL] [Abstract][Full Text] [Related]
5. Activated conformations of the ras-gene-encoded p21 protein. 2. Comparison of the computed and high-resolution x-ray crystallographic structures of Gly-12 p21.
Dykes DC; Brandt-Rauf P; Luster SM; Friedman FK; Pincus MR
J Biomol Struct Dyn; 1993 Apr; 10(5):905-18. PubMed ID: 8318164
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.
Chen JM; Lee G; Murphy RB; Carty RP; Brandt-Rauf PW; Friedman E; Pincus MR
J Biomol Struct Dyn; 1989 Apr; 6(5):859-75. PubMed ID: 2686707
[TBL] [Abstract][Full Text] [Related]
7. Ligand-induced conformational changes in ras p21: a normal mode and energy minimization analysis.
Ma J; Karplus M
J Mol Biol; 1997 Nov; 274(1):114-31. PubMed ID: 9398520
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic amino acid substitutions in the inhibitory rap-1A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics.
Chen JM; Brandt-Rauf PW; Pincus MR
J Biomol Struct Dyn; 1996 Jun; 13(6):925-33. PubMed ID: 8832375
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics of the H-ras gene-encoded p21 protein; identification of flexible regions and possible effector domains.
Dykes DC; Friedman FK; Dykes SL; Murphy RB; Brandt-Rauf PW; Pincus MR
J Biomol Struct Dyn; 1993 Dec; 11(3):443-58. PubMed ID: 8129867
[TBL] [Abstract][Full Text] [Related]
10. An NMR comparison of the changes produced by different guanosine 5'-triphosphate analogs in wild-type and oncogenic mutant p21ras.
Miller AF; Halkides CJ; Redfield AG
Biochemistry; 1993 Jul; 32(29):7367-76. PubMed ID: 8338834
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ras-p21 bound to GDP and GTP: differences in protein and ligand dynamics.
Mello LV; van Aalten DM; Findlay JB
Protein Eng; 1997 Apr; 10(4):381-7. PubMed ID: 9194162
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the average structures, from molecular dynamics, of complexes of GTPase activating protein (GAP) with oncogenic and wild-type ras-p21: identification of potential effector domains.
Chen JM; Friedman FK; Brandt-Rauf PW; Pincus MR; Chie L
J Protein Chem; 2002 Jul; 21(5):349-59. PubMed ID: 12206509
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.
Tong LA; de Vos AM; Milburn MV; Kim SH
J Mol Biol; 1991 Feb; 217(3):503-16. PubMed ID: 1899707
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulation of the solution structures of Ha-ras-p21 GDP and GTP complexes: flexibility, possible hinges, and levers of the conformational transition.
Díaz JF; Wroblowski B; Engelborghs Y
Biochemistry; 1995 Sep; 34(37):12038-47. PubMed ID: 7547942
[TBL] [Abstract][Full Text] [Related]
15. Development of new anti-cancer peptides from conformational energy analysis of the oncogenic ras-p21 protein and its complexes with target proteins.
Pincus MR
Front Biosci; 2004 Sep; 9():3486-509. PubMed ID: 15353372
[TBL] [Abstract][Full Text] [Related]
16. GTP hydrolysis mechanisms in ras p21 and in the ras-GAP complex studied by fluorescence measurements on tryptophan mutants.
Antonny B; Chardin P; Roux M; Chabre M
Biochemistry; 1991 Aug; 30(34):8287-95. PubMed ID: 1883817
[TBL] [Abstract][Full Text] [Related]
17. Proton NMR studies of transforming and nontransforming H-ras p21 mutants.
Schlichting I; John J; Frech M; Chardin P; Wittinghofer A; Zimmermann H; Rösch P
Biochemistry; 1990 Jan; 29(2):504-11. PubMed ID: 2405906
[TBL] [Abstract][Full Text] [Related]
18. The structural basis for the transition from Ras-GTP to Ras-GDP.
Hall BE; Bar-Sagi D; Nassar N
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12138-42. PubMed ID: 12213964
[TBL] [Abstract][Full Text] [Related]
19. Conformations of the central transforming region (Ile 55-Met 67) of the p21 protein and their relationship to activation of the protein.
Chen JM; Lee G; Brandt-Rauf PW; Murphy RB; Gibson KD; Scheraga HA; Rackovsky S; Pincus MR
Int J Pept Protein Res; 1990 Sep; 36(3):247-54. PubMed ID: 2279848
[TBL] [Abstract][Full Text] [Related]
20. Conformational effects of amino acid substitutions at positions 10, 12, and 13 in the P21 protein.
Brandt-Rauf PW; Pincus MR; Carty RP; Lubowsky J; Avitable M; Kung HF; Maizel J
J Protein Chem; 1989 Feb; 8(1):79-86. PubMed ID: 2669815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
